UBS Group’s ETRACS Alerian MLP Index ETN Series B due July 18 2042 AMUB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$2.05K 10223
2025
Q1
$2.05K Sell
100
-20
-17% -$403 ﹤0.01% 9407
2024
Q4
$2.22K Buy
+120
New +$2.22K ﹤0.01% 9086
2024
Q3
Sell
-16
Closed -$291 9471
2024
Q2
$291 Buy
+16
New +$284 ﹤0.01% 8999
2023
Q1
Sell
-2,549
Closed -$34.9K 9556
2022
Q4
$34.9K Buy
2,549
+2,457
+2,671% +$34K ﹤0.01% 7088
2022
Q3
$1K Buy
92
+10
+12% +$132 ﹤0.01% 9915
2022
Q2
$1K Buy
+82
New +$1.09K ﹤0.01% 9809
2019
Q4
Sell
-200
Closed -$3K 8086
2019
Q3
$3K Hold
200
﹤0.01% 7614
2019
Q2
$3K Hold
200
﹤0.01% 7518
2019
Q1
$3K Hold
200
﹤0.01% 7320
2018
Q4
$3K Hold
200
﹤0.01% 7703
2018
Q3
$3K Hold
200
﹤0.01% 7639
2018
Q2
$3K Hold
200
﹤0.01% 7614
2018
Q1
$3K Buy
+200
New +$3.39K ﹤0.01% 7405

Other funds holding AMUB

UBS Group's AMUB Position: Q2 2025 in Review

UBS Group sold out of ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) in Q2 2025, closing a stake of 100 shares — an estimated $2.05K sold.

UBS Group first reported a position in AMUB in Q1 2018 and held it in 13 quarters. The position peaked at $34.9K in Q4 2022. 7 funds tracked by Wall St. Rank hold AMUB as of Q2 2025.

  • UBS Group reported no remaining ETRACS Alerian MLP Index ETN Series B due July 18 2042 position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 100 ETRACS Alerian MLP Index ETN Series B due July 18 2042 shares in Q2 2025, an estimated $2.05K.
  • UBS Group first reported a position in ETRACS Alerian MLP Index ETN Series B due July 18 2042 in Q1 2018 and held it in 13 quarters.
  • UBS Group's ETRACS Alerian MLP Index ETN Series B due July 18 2042 position peaked at $34.9K in Q4 2022.
  • 7 funds tracked by Wall St. Rank held ETRACS Alerian MLP Index ETN Series B due July 18 2042 as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.